Abstract
Background: The indications for neoadjuvant breast cancer treatment have expanded rapidly in recent decades. Administration of chemotherapy before surgery has the potential to reduce the risk of distant recurrence by targeting circulating micrometastases as well as allowing a more minimalistic approach to surgical intervention. This study aimed to determine the optimum timing of surgery post breast cancer neoadjuvant chemotherapy (NACT).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have